48 minutes agoBusiness
37LENS
3 SourcesIndia
thebalanced.newsSmall-, Mid-Cap and Pharma Stocks Outperform Amid US-Iran Conflict in 2026
In 2026, small- and mid-cap stocks in India have outperformed large caps despite geopolitical tensions from the US-Iran conflict. The Nifty Smallcap 100 and Midcap 100 indices posted positive returns, driven by strong earnings and favorable outlooks in sectors like defence, metals, and chemicals. Midcap stocks such as BHEL and Ola Electric saw gains up to 51%. The pharma sector also rallied, with the Nifty Pharma index rising 9.4% YTD, led by Gland Pharma and Biocon, while large caps and certain sectors like technology and finance faced declines.
Political Bias
0%100%0%
Sentiment
72%
AI Analysis
Political bias across 3 sources
● Left 0%● Center 100%● Right 0%
The articles present a primarily economic and market-focused perspective without explicit political bias. They highlight stock performance amid geopolitical tensions, referencing the US-Iran conflict as context but focusing on financial data and sectoral trends. The coverage includes both positive and negative market movements, reflecting a balanced economic viewpoint rather than political framing.
Sentiment — Positive (72/100)
The overall sentiment is mixed to positive, emphasizing gains in small-, mid-cap, and pharma stocks despite broader market challenges. While acknowledging declines in large caps and certain sectors, the tone remains factual and optimistic about specific sectors' resilience and growth, avoiding sensationalism related to geopolitical risks.
How 3 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| mint | BSE, SAIL to HFCL: Midcap, smallcap stocks jump up to 112 YTD despite US-Iran war; will their outperformance continue? Stock Market News | Center | Positive |
| mint | Gland Pharma to Biocon: Pharma stocks rally up to 27 in a month: Can they shield portfolio from US-Iran war-led risks? Stock Market News | Center | Positive |
| economictimes | 10 midcap stocks that rallied up to 51 since the West Asia conflict began - War Winners | Center | Positive |
Coverage timeline
economictimes broke this story on 21 May, 06:30 am. Other outlets followed.
- 1economictimes21 May, 06:30 am10 midcap stocks that rallied up to 51 since the West Asia conflict began - War Winners
- 2mint21 May, 07:07 amGland Pharma to Biocon: Pharma stocks rally up to 27 in a month: Can they shield portfolio from US-Iran war-led risks? Stock Market News
- 3mint21 May, 10:55 amBSE, SAIL to HFCL: Midcap, smallcap stocks jump up to 112 YTD despite US-Iran war; will their outperformance continue? Stock Market News
Lens Score breakdown
37/100
Public interest0/100
Coverage gap90%
Story is receiving appropriate media attention relative to public interest.
Who's involved
Institutions and figures named across source coverage.
Corporate
LupinMankind PharmaAjanta PharmaNatco PharmaAbbott IndiaGlenmark PharmaceuticalsZydus LifesciencesAurobindo PharmaDivi's LaboratoriesSuzlon EnergyOla Electric MobilityCiplaLloyds Metals EnergyGranules IndiaIpca LaboratoriesAlkem LaboratoriesJB Chemicals PharmaceuticalsLaurus LabsGland PharmaThermaxOracle Financial Services SoftwareBharat Heavy ElectricalsBioconTorrent PharmaceuticalsDr Reddy's LaboratoriesPremier EnergiesPhysicswallahSun Pharmaceutical IndustriesHitachi Energy India
Story context
- Category
- Business
- Location
- India
- Sources analysed
- 3
- Last analysed
- 21 May 2026
- Key entities
- IndiaStockNIFTY 50Chemical industryInformation technologyIndian rupeeGeopoliticsLaurus LabsMarket capitalizationHFCLSteel Authority of IndiaVolatility (finance)
Related Coverage
Select a news story to see related coverage from other media outlets.